HRV and sleep quality: 8 weeks on CJC-1295/Ipamorelin
I wanted to share some data after hitting the 8-week mark on my CJC-1295/Ipamorelin protocol. I've been tracking everything via my Oura ring and the results have been pretty consistent. Before starting, my average HRV was hovering around 35ms, and I was struggling with deep sleep cycles. As of this morning, my HRV is up to 52ms, and my deep sleep duration has increased by about 45 minutes on average. I'm currently dosing 100mcg of each, 5 nights a week, right before bed. I haven't noticed any major side effects other than some mild water retention in the first two weeks, which subsided quickly. It feels great to have a reliable, pharmacy-grade supply again after the uncertainty earlier this year. Has anyone else noticed these kinds of recovery metrics improving, or is it just the placebo effect of finally getting better sleep?
That is an impressive improvement in your biometric data. It is well-documented that the CJC-1295/Ipamorelin combination works by stimulating the anterior pituitary gland to release endogenous growth hormone in a pulsatile fashion. By administering this shortly before bed, you are essentially amplifying your natural nocturnal growth hormone spike, which directly correlates with the restorative deep sleep phases you are seeing increased. The improvement in HRV suggests that your autonomic nervous system is recovering much more efficiently, likely due to reduced systemic inflammation and improved metabolic recovery during those extended deep sleep stages. Since you are hitting the 8-week mark, many users start considering a brief reset or cycling off for a few weeks to maintain pituitary sensitivity and ensure your endogenous feedback loops remain balanced. Have you noticed any changes in your morning fasting glucose levels, or are you just tracking sleep metrics for now? Remember that this is just community experience sharing, so keep consulting with your provider regarding your bloodwork markers during this protocol.